AeroSafe Global

AeroSafe Global

The proven end-to-end solution for the biopharma industry and its mission-critical, cold-chain operations.

Founded 1995

Rochester, United States 109 employees Private Equity Total: $162.68M Biopharma, Logistics +2

AeroSafe Global is a biopharma industry focused startup, offering an end-to-end solution for cold-chain operations. Founded in 1995 and headquartered in the United States, the company has garnered significant attention and recently received a $43.00M Private Equity Round investment on 29 August 2023. The investment was led by several prominent firms including NewSpring Capital, Escalate Capital Partners, Flexstone Partners, Hamilton Lane, Peloton Equity, WAVE Equity Partners, and the Merck Global Health Innovation Fund. AeroSafe Global's value proposition lies in providing reliable, simple, and sustainable temperature-sensitive supply chain solutions for leading biopharma companies. Their "Cold Chain as a Service" (CSaaS) offering encompasses state-of-the-art packaging design, technology-enabled logistics programs, and cost-reducing operational services. This approach aims to reduce complexity, increase flexibility, and create a sustainable and reliable solution for their valued customers. With a focus on the biopharma, manufacturing, and pharmaceutical industries, AeroSafe Global is positioning itself as a key player in the mission-critical cold-chain operations, presenting an enticing opportunity for investors seeking exposure in this niche and rapidly evolving sector.

Funding Stage	Amount	Investors	Lead Investors	Date
Private Equity Round	$43.00M	7	Escalate Capital Partners, Flexstone Partners +5	29 Aug 2023
Venture Round	$47.50M	7	Escalate Capital Partners, Flexstone Partners +5	10 Sep 2020
Venture Round	$31.50M	3	Flexstone Partners, Hamilton Lane +1	24 Jul 2019
Venture Round	$5.57M	-		06 Jul 2018
Venture Round	$1.25M	-		30 Sep 2016
Venture Round	$10.39M	-		12 Dec 2015
Venture Round	$5.09M	-		31 Jul 2015
Venture Round	$2.50M	-		20 Apr 2014
Venture Round	$4.69M	-		11 Feb 2013
Debt Financing	Undisclosed	-		26 May 2011

Funding Stage

Amount

Investors

Lead Investors

Date

Private Equity Round

$43.00M

Escalate Capital Partners, Flexstone Partners +5

29 Aug 2023

Venture Round

$47.50M

Escalate Capital Partners, Flexstone Partners +5

10 Sep 2020

Venture Round

$31.50M

Flexstone Partners, Hamilton Lane +1

24 Jul 2019

Venture Round

$5.57M

06 Jul 2018

Venture Round

$1.25M

30 Sep 2016

Venture Round

$10.39M

12 Dec 2015

Venture Round

$5.09M

31 Jul 2015

Venture Round

$2.50M

20 Apr 2014

Venture Round

$4.69M

11 Feb 2013

Debt Financing

Undisclosed

26 May 2011

FAQ About AeroSafe Global

The proven end-to-end solution for the biopharma industry and its mission-critical, cold-chain operations.

AeroSafe Global was founded in 1995.

AeroSafe Global is headquartered in Rochester, United States.

AeroSafe Global operates in Biopharma, Logistics, Manufacturing and Pharmaceutical. Its work centres on Cold Chain Solutions, Biopharma Industry, Temperature-Sensitive Shipping and Supply Chain.

AeroSafe Global has approximately 109 employees.

AeroSafe Global has completed 12 funding rounds, raising a total of $162.68M. The latest funding stage is Private Equity.

Top alternatives and competitors to AeroSafe Global include KROSSLINKER Aerogel Solutions, NL Cold Chain Network (M) Sdn. Bhd., Nordic Cold Chain Solutions, TemperPack, Liviri. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

AeroSafe Global and KROSSLINKER Aerogel Solutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About AeroSafe Global

Funding Rounds & Investors (12)

AeroSafe Global Alternatives & Competitors

FAQ About AeroSafe Global